- Home
- SPPP vs VYGR Comparison
SPPP vs VYGR Comparison
Compare SPPP & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPPP
- VYGR
- Stock Information
- Founded
- SPPP 2011
- VYGR 2013
- Country
- SPPP Canada
- VYGR United States
- Employees
- SPPP N/A
- VYGR N/A
- Industry
- SPPP
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- SPPP
- VYGR Health Care
- Exchange
- SPPP NYSE
- VYGR Nasdaq
- Market Cap
- SPPP 172.2M
- VYGR 164.3M
- IPO Year
- SPPP N/A
- VYGR 2015
- Fundamental
- Price
- SPPP $11.94
- VYGR $3.04
- Analyst Decision
- SPPP
- VYGR Strong Buy
- Analyst Count
- SPPP 0
- VYGR 8
- Target Price
- SPPP N/A
- VYGR $14.33
- AVG Volume (30 Days)
- SPPP 183.3K
- VYGR 702.1K
- Earning Date
- SPPP 01-01-0001
- VYGR 08-05-2025
- Dividend Yield
- SPPP N/A
- VYGR N/A
- EPS Growth
- SPPP N/A
- VYGR N/A
- EPS
- SPPP N/A
- VYGR N/A
- Revenue
- SPPP N/A
- VYGR $66,958,000.00
- Revenue This Year
- SPPP N/A
- VYGR N/A
- Revenue Next Year
- SPPP N/A
- VYGR $78.88
- P/E Ratio
- SPPP N/A
- VYGR N/A
- Revenue Growth
- SPPP N/A
- VYGR N/A
- 52 Week Low
- SPPP $8.55
- VYGR $2.65
- 52 Week High
- SPPP $11.39
- VYGR $9.55
- Technical
- Relative Strength Index (RSI)
- SPPP 59.78
- VYGR 45.57
- Support Level
- SPPP $11.57
- VYGR $2.83
- Resistance Level
- SPPP $12.46
- VYGR $3.43
- Average True Range (ATR)
- SPPP 0.26
- VYGR 0.18
- MACD
- SPPP -0.01
- VYGR 0.01
- Stochastic Oscillator
- SPPP 58.33
- VYGR 35.00
About SPPP SPROTT PHYS PLATINUM & PALLADIUM
Sprott Physical Platinum & Palladium Tr invests and holds all of its assets in physical platinum and palladium bullion. The company seeks to provide a secure, convenient, and exchange-traded investment alternative for investors interested in holding physical platinum and palladium bullion without the inconvenience that is typical of a direct investment in physical bullion. The Trust invests mainly in long-term holdings of unencumbered, fully allocated, physical platinum and palladium bullion.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.